New Migraine Drugs Signal Hope for Millions
Over the past 50 years there hasn't been a single preventative drug developed that specifically targets migraines. But new research in its early stages shows hope that a preventative drug may be within...
View ArticleAstraZeneca Board Rejects New Offer From Pfizer
The board of directors of British drug maker AstraZeneca says it rejects the raised $119 billion takeover offer from U.S. drugmaker Pfizer. In a statement released Monday, AstraZeneca's board said it...
View ArticleSon's Rare Cancer Leads Family On Quest For Cure
When a child falls ill with cancer, many of the drugs that might help are either experimental or unapproved for use in kids.
View ArticleRainforest Remedies
The Topes de Collante nature reserve is nestled In the mountains southeast of Havana. We go for a hike with naturalist Andres Santana Diaz, who points out various natural remedies from rainforest plants.
View ArticlePharmaceuticals: Brain power
Alzheimer's affects tens of millions of people around the world and the goal of an effective treatment has been so elusive that it is seen as a 'black hole' for drugs spending. But now Andrew Ward and...
View ArticleHillary Clinton Wants a Price Check on Drugs
Hillary Clinton has unveiled a plan aimed at pharmaceutical companies and sky-rocketing drug prices. Most notably, she wants to allow the government to negotiate lower prices for prescription...
View ArticlePfizer, Allergan Combining in $160 Billion Deal
Pfizer and Allergan will merge in a $160 billion deal to create the world's largest drugmaker. The transaction is valued at $363.63 per Allergan share. Allergan shareholders will receive 11.3 shares of...
View ArticleHow Drug Shortages Determine Who Gets Treatment
Hospitals across the country have been facing chronic drug shortages for years, and the problem is getting worse. New York Times correspondent Sheri Fink and Dr. Yoram Unguru, an oncologist at the...
View ArticleClik here to view.
Lower drug prices: Does any candidate have an Rx?
The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office. Photo by Mike...
View ArticleLove in the Time of Pharmaceuticals
Director David Cromer joins us to discuss “The Effect”, now playing at the Barrow Street Theatre (27 Barrow Street) through September 4th. Starring Steve Key and Kati Brazda, it follows a love story...
View ArticleClik here to view.
Did outcry on social media lead to Mylan’s generic EpiPen?
Watch Video | Listen to the AudioGWEN IFILL: Drugmaker Mylan has been under heavy fire for its soaring price hikes for EpiPens, the lifesaving necessity for those with serious allergic reactions.Its...
View ArticleClik here to view.
Investments by Trump’s HHS pick raise questions over conflict of interest
Chairman of the House Budget Committee Tom Price (R-GA) announces the House Budget during a press conference on Capitol Hill in Washington on March 17, 2015. Photo by Joshua Roberts/File...
View ArticleThe Global Consequences of the U.S. Opioid Epidemic
Jonathan Capehart guest hosts today!Harriet Ryan, investigative reporter for The Los Angeles Times, joins us to discuss her three-part series, co-written with Lisa Girion and Scott Glover, about...
View ArticleClik here to view.
Tom Price, Trump’s HHS nominee, got a sweetheart deal from a foreign biotech...
Representative Tom Price (R-GA), President-elect Donald Trump’s nominee to be secretary of health and human services, arrives to meet with U.S. Senator Chuck Grassley in Grassley’s office on Capitol...
View ArticleClik here to view.
Why kid-friendly medications can be expensive for parents
The challenge of getting sick children the kind of medication they can take and tolerate — often by creating liquid formulations of drugs that are already on the market — is seen by some companies as a...
View ArticleMartin ‘Pharma Bro’ Shkreli on Trial
Martin Shkreli is often described as the "most hated man in America” for raising the price of a lifesaving drug by 5,000%, earning him the nickname "Pharma bro."Shkreli said his pharmaceutical company...
View ArticlePharmaceuticals in the Hudson Pose a Threat to Aquatic Life
According to the co-author of a study measuring trace pharmaceuticals in the Hudson River, fish and other forms of aquatic life may be experiencing harm from the contaminants, which are more widespread...
View ArticleFull Show: Bring On The Competition
First, U.S. News releases its college rankings each year to much fanfare. But are they actually hurting higher ed? We ask journalist Scott Jaschik and U.S. News’ Robert Morse. Then, there will be 10...
View ArticleHow Your Health Data Gets Sold
In 2017, the fact that companies have access to personal data about us is common knowledge. But the data available to companies goes beyond just what websites you browse and where you’ve checked in on...
View ArticleHow Big Pharma Pushed Fentanyl
Julia Lurie discusses her recent piece in Mother Jones“‘Behave More Sexually:’ How Big Pharma Used Strippers, Guns, and Cash to Push Opioids.” Lurie looks at the tactics used by sales representatives...
View Article
